Patent applications and USPTO patent grants for McMurtrie; Darren.The latest application filed is for "pyrazole compounds and methods for making and using the compounds".
Patent | Date |
---|---|
Pyrazole Compounds And Methods For Making And Using The Compounds App 20220289776 - Kelley; Ryan ;   et al. | 2022-09-15 |
Pyrazole compounds and methods for making and using the compounds Grant 11,370,808 - Kelley , et al. June 28, 2 | 2022-06-28 |
Irak Inhibitors And Method For Making And Using App 20210179601 - Li; Hui ;   et al. | 2021-06-17 |
IRAK inhibitors and method for making and using Grant 10,941,140 - Li , et al. March 9, 2 | 2021-03-09 |
Irak Inhibitors And Method For Making And Using App 20190300518 - Li; Hui ;   et al. | 2019-10-03 |
IRAK inhibitors and method for making and using Grant 10,370,367 - Li , et al. | 2019-08-06 |
Pyrazole Compounds And Methods For Making And Using The Compounds App 20190153006 - Kelley; Ryan ;   et al. | 2019-05-23 |
Pyrazole compounds and method for making and using the compounds Grant 10,208,074 - Kelley , et al. Feb | 2019-02-19 |
Pyrazole compounds and method for making and using the compounds Grant 10,208,075 - Kelley , et al. Feb | 2019-02-19 |
Pyrazole Compounds And Method For Making And Using The Compounds App 20180208612 - Kelley; Ryan ;   et al. | 2018-07-26 |
Pyrazole Compounds And Method For Making And Using The Compounds App 20180208613 - Kelley; Ryan ;   et al. | 2018-07-26 |
Pyrazole compounds and method for making and using the compounds Grant 9,982,000 - Kelley , et al. May 29, 2 | 2018-05-29 |
Irak Inhibitors And Method For Making And Using App 20180111923 - Li; Hui ;   et al. | 2018-04-26 |
Protein kinase C inhibitors and uses thereof Grant 9,913,843 - Kolluri , et al. March 13, 2 | 2018-03-13 |
Pyrazole Compounds And Method For Making And Using The Compounds App 20160311839 - Kelley; Ryan ;   et al. | 2016-10-27 |
Dual-acting benzoimidazole antihypertensive agents Grant 9,198,899 - Allegretti , et al. December 1, 2 | 2015-12-01 |
Protein Kinase C Inhibitors And Uses Thereof App 20150306100 - Kolluri; Rao ;   et al. | 2015-10-29 |
Dual-acting antihypertensive agents Grant 9,150,514 - Allegretti , et al. October 6, 2 | 2015-10-06 |
Protein kinase C inhibitors and uses thereof Grant 9,062,068 - Kolluri , et al. June 23, 2 | 2015-06-23 |
Pyrimidinediamine kinase inhibitors Grant 9,040,527 - Singh , et al. May 26, 2 | 2015-05-26 |
Dual-acting Antihypertensive Agents App 20150065543 - Allegretti; Paul ;   et al. | 2015-03-05 |
Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity Grant 8,895,755 - Allegretti , et al. November 25, 2 | 2014-11-25 |
Protein Kinase C Inhibitors And Uses Thereof App 20140163022 - Kolluri; Rao ;   et al. | 2014-06-12 |
Dual-acting Benzoimidazole Antihypertensive Agents App 20140107120 - Allegretti; Paul ;   et al. | 2014-04-17 |
Dual-acting benzoimidazole antihypertensive agents Grant 8,637,676 - Allegretti , et al. January 28, 2 | 2014-01-28 |
Dual-acting Antihypertensive Agents App 20140024835 - Allegretti; Paul ;   et al. | 2014-01-23 |
Pyrimidinediamine Kinase Inhibitors App 20130309228 - Singh; Rajinder ;   et al. | 2013-11-21 |
Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity Grant 8,569,351 - Allegretti , et al. October 29, 2 | 2013-10-29 |
Dual-acting Imidazole Antihypertensive Agents App 20130245087 - Allegretti; Paul ;   et al. | 2013-09-19 |
Pyrimidinediamine kinase inhibitors Grant 8,518,937 - Singh , et al. August 27, 2 | 2013-08-27 |
Dual-acting Antihypertensive Agents App 20130096162 - Allegretti; Paul ;   et al. | 2013-04-18 |
Compositions and methods for inhibition of the JAK pathway Grant 8,420,659 - Bhamidipati , et al. April 16, 2 | 2013-04-16 |
Pyrimidinediamine Kinase Inhibitors App 20130012501 - Singh; Rajinder ;   et al. | 2013-01-10 |
Dual-acting antihypertensive agents Grant 8,349,875 - Allegretti , et al. January 8, 2 | 2013-01-08 |
Dual-acting imidazole antihypertensive agents Grant 8,344,013 - Allegretti , et al. January 1, 2 | 2013-01-01 |
Compositions And Methods For Inhibition Of The Jak Pathway App 20120301486 - Bhamidipati; Somasekhar ;   et al. | 2012-11-29 |
Dual-acting Antihypertensive Agents App 20120264752 - Allegretti; Paul ;   et al. | 2012-10-18 |
Pyrimidinediamine kinase inhibitors Grant 8,278,299 - Singh , et al. October 2, 2 | 2012-10-02 |
Compositions and methods for inhibition of the JAK pathway Grant 8,268,851 - Bhamidipati , et al. September 18, 2 | 2012-09-18 |
Dual-acting antihypertensive agents Grant 8,236,846 - Allegretti , et al. August 7, 2 | 2012-08-07 |
Dual-acting Imidazole Antihypertensive Agents App 20120165381 - Allegretti; Paul ;   et al. | 2012-06-28 |
Dual-acting imidazole antihypertensive agents Grant 8,158,659 - Allegretti , et al. April 17, 2 | 2012-04-17 |
Dual-acting Antihypertensive Agents App 20110281925 - Allegretti; Paul ;   et al. | 2011-11-17 |
Dual-acting antihypertensive agents Grant 8,013,005 - Allegretti , et al. September 6, 2 | 2011-09-06 |
Dual-acting Imidazole Antihypertensive Agents App 20110092551 - ALLEGRETTI; Paul ;   et al. | 2011-04-21 |
Dual-acting imidazole antihypertensive agents Grant 7,879,896 - Allegretti , et al. February 1, 2 | 2011-02-01 |
Pyrimidinediamine Kinase Inhibitors App 20100179134 - Singh; Rajinder ;   et al. | 2010-07-15 |
Compositions And Methods For Inhibition Of The Jak Pathway App 20100158921 - Bhamidipati; Somasekhar ;   et al. | 2010-06-24 |
Dual-acting Imidazole antihypertensive agents App 20090023228 - Allegretti; Paul ;   et al. | 2009-01-22 |
Dual-acting benzoimidazole antihypertensive agents App 20080318951 - Allegretti; Paul ;   et al. | 2008-12-25 |
Dual-acting antihypertensive agents App 20080269305 - Allegretti; Paul ;   et al. | 2008-10-30 |
Antiviral compounds App 20070078081 - Casarez; Anthony ;   et al. | 2007-04-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.